Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Lilly claims TGF-beta signal transduction inhibitors

July 19, 2004

Phase I trial for new formulation of 17-AAG in multiple myeloma

July 19, 2004

Antitumor sulfonamides claimed by Lilly

July 16, 2004

Elan to produce reformulated Panzem for EntreMed oncology program

July 16, 2004

Fourth phase II study of PI-88 launches

July 16, 2004

Encouraging results for MF-5232 for mucositis

July 16, 2004

Potent uPA inhibitor selected for clinical evaluation at Pfizer

July 16, 2004

Imiquimod in the treatment of AIN in HIV-infected men

July 16, 2004

Silicon compounds for the treatment of cancer reported by Amedis

July 15, 2004

Inhibitors of kinases claimed by Schering AG

July 15, 2004

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...